Research · Sep 3, 2026
PPC Pilgrim's Pride Thesis 2026: Global Chicken Protein Drives European Prepared Foods Capital Return
Pilgrim's Pride Corporation (NASDAQ: PPC) FY2026 thesis centers on continued US + Mexico Chicken Protein pipeline (~$14.0-15.0B revenue) + Europe + UK Chicken + Prepared Foods pipeline (~$4.5-4.9B revenue) under continued President + CEO Fabio Sandri since June 2021 (~4-year tenure as Pilgrim's Pride CEO; selected post-June 2021 succession from Jayson Penn departure; selected post-2014 Brazil JBS S.A. ~80% majority ownership stake; selected primary architect of post-2021 European + UK prepared foods expansion + post-2023-2024 US chicken margin recovery initiative). FY2025 revenue ~$18.50-19.50B (+5-10% YoY) with adj. EPS ~$5.85-6.50 reflecting continued ~$2.0-2.4B aggregate adj. EBITDA. PPC operates 3 primary segments: US chicken ~62-66% revenue ($11.5-12.2B) + Mexico chicken ~13-15% revenue ($2.5-2.8B) + Europe + UK chicken + prepared foods ~22-26% revenue ($4.5-4.9B). US + Mexico Chicken Protein pipeline (~$14.0-15.0B revenue): selected primary US chicken (~$11.5-12.2B; selected primary #2 aggregate US chicken processor ~18-20% aggregate US chicken market share behind Tyson Foods #1 ~22-25%) + selected various aggregate Pilgrim's + Just Bare + Gold'n Plump + retail + foodservice + export channel + selected various aggregate Mexico chicken (~$2.5-2.8B; selected primary #1 aggregate Mexico chicken processor + Pilgrim's Mexico market position) + selected various aggregate post-2023-2024 US chicken margin recovery + breast meat + dark meat + small bird + commodity chicken cycle. Europe + UK Chicken + Prepared Foods pipeline (~$4.5-4.9B revenue): selected primary Moy Park UK (~$2.6-2.9B; #1 UK chicken processor + Northern Ireland + UK retail + foodservice channel) + Tulip Ltd UK (~$0.85-1.05B; UK + Ireland pork + prepared foods) + Pilgrim's Food Masters European prepared foods (~$1.0-1.1B; Continental Europe + UK prepared foods + meal solutions + post-2021-2023 European prepared foods M&A integration including Kerry Consumer Foods) + selected various aggregate post-2021-2025 European prepared foods + value-added margin expansion. Capital position + balance sheet: ~$6.30 aggregate special dividend (post-March 2025 inaugural $6.30 special dividend = ~$1.5B aggregate special dividend payout; ~50-55% payout ratio; ~9.5-11.5% special dividend yield equivalent at announcement) + no aggregate regular annual dividend + ~$25-200M aggregate FY2025 buybacks + aggregate capital return ~$1,525-1,700M FY2025 + net leverage ~1.0-1.5x + investment-grade BBB-/BB+ split-rated credit rating + ~237-239M diluted shares. FY2026 base case ~$19.50-20.60B aggregate revenue + ~$6.20-6.95 adj. EPS + ~$0-1.8B aggregate special dividend potential; bull case US + Mexico Chicken Protein pipeline acceleration (US chicken margin recovery continuation + breast meat + dark meat + small bird ASP recovery + Mexico chicken market #1 share leverage) + Europe + UK Chicken + Prepared Foods pipeline acceleration (Moy Park UK + Tulip Ltd + Pilgrim's Food Masters value-added margin expansion) + post-March 2025 inaugural $6.30 special dividend precedent FY2026 periodic special dividend continuation drives ~$20.30-21.50B aggregate revenue + ~$7.05-7.85 EPS; bear case Tyson Foods + Sanderson Farms + Wayne-Sanderson + Perdue Farms + Mountaire + Foster Farms + Industrias Bachoco competitive intensification + 2 Sisters Food Group + Cranswick + Hilton Food + Kerry Group + Cargill + Nestlé + Unilever UK + European competitive intensification + commodity chicken cycle downturn + breast meat + dark meat ASP cycle weakness + corn + soybean feed cost cycle elevated + UK retail channel concentration considerations + Brexit + UK regulatory considerations + avian influenza (HPAI) cycle considerations + JBS S.A. parent capital allocation considerations + post-June 2021 Fabio Sandri CEO succession planning considerations drives ~$17.85-18.75B revenue + ~$4.80-5.40 EPS.